Healthcare Nanotechnology Market Size, Share Report, 2024 | Hexa Research

Page 1

Your Catalyst To a Lucrative Business

Healthcare Nanotechnology Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 | Hexa Research

“Continuous innovation in nanotechnology for improvement of nanomedicines is the main driver for nanotechnology market by 2024.�

The global Healthcare Nanotechnology Market is anticipated to grow at a CAGR surpassing 12% from 2016 to 2024 (forecast period). This market is primarily driven by technological advancements & innovations in nanotechnology. Nanotechnology in healthcare aims at curing molecular & submicroscopic parts by monitoring & repairing, and by reconstructing them. This industry is propelled by development initiatives that are funded by government & private organizations that focus on neurological & cardiovascular ailments. Focus on enhancing drug efficiency also has a favorable impact on market demand. Nanotechnology is expe cted to gain importance in the areas of disease prevention, diagnosis, and therapy. The global healthcare nanotechnology market is segmented on the basis of applications, end users, and regions. On the basis of applications, the industry is categorized into clinical cardiology, drug delivery systems, clinical neurology, molecular diagnostics, clinical oncology, and anti-inflammatory & anti-infective applications. The other applications are kidney andophthalmology, dental, hematology, and orthopedic. Clinic al oncology is a rapidly growing segment due to the efficacy of nano particles to fight against cancerous tissues & tumors. Browse Details of Report @ https://www.hexaresearch.com/research-report/healthcare-nanotechnologyindustry

Follow Us:


Your Catalyst To a Lucrative Business High incidence of cardiovascular anomalies can augment the cardiovascular segment over the forecast period. The market for nanotechnology applications in cardiology holds high growth potential in most developing & underdeveloped economies. The anti-infective segment is projected to expand considerably because of rising prevalence of air-borne diseases, bird flu, and swine flu. Based on end users, the market is trifurcated i nto ambulatories, clinics, and hospitals. The hospitals segment may expand substantially owing to rising cases of chronic ailments and high awareness about disease prevention. A number of large and medium sized hospitals have begun adopting nanotechnology . Unlike small hospitals that have limited resources, the large ones can adopt newer technologies because of favorable budgetary conditions. Geographically, the global industry is divided into Asia Pacific, North America, Europe, and Rest of the World. North America held the highest share in terms of revenue in 2014. Factors, such as high investments and sophisticated technologies can fuel this region in the forthcoming years. Ongoing industry trends suggest that Asia Pacific may register a high rate of growth at the same time. Key regional drivers are surging disposable incomes, outsourcing of healthcare services, and growing population. Prominent companies operating in the worldwide healthcare nanotechnology market are Celgene Corporation, CombiMatrix Corporation, Johnson & Johnson, Abbott Laboratories, and Teva Pharmaceuticals Industries Ltd. Characterized by stiff competition, the industry witnesses frequent business ventures and regional expansion initiatives. Researchers & scientists are trying to develop nanosensors that can detect the occurrence of heart attacks (myocardial infarction). This could not only save lives but also money. Such a technology uses miniature blood stream nanosensors chips that can sense the onset of a heart attack. An individual with the help of this tiny chip can receive a warning on some wireless device or smartphone to immediately seek medical help. The updated version of this chip measures only ninety microns (a size way lesser than a sand grain). This combination of a smartphone and a nanosensor may even help detect certain types of cancers and autoimmune diseases. These sensors are mostly used in animals for glucose detection. Browse Related Category Market Reports @ https://www.hexaresearch.com/researchcategory/biotechnology-industry

Follow Us:


Your Catalyst To a Lucrative Business Table of Content of Healthcare Nanotechnology Market Chapter 1. Executive Summary 1.1. Nanotechnology Healthcare - Industry Summary & Critical Success Factors (CSFs) Chapter 2. Nanotechnology Healthcare Industry Outlook 2.1. Market Segmentation 2.2. Market Size and Growth Prospects 2.3. Nanotechnology Healthcare Market Dynamics 2.3.1. Market Driver Analysis 2.3.1.1. Growing incidences of chronic severe diseases 2.3.1.2. Technological innovation in medical application of nanotechnology 2.3.1.3. Growing geriatric population base 2.4. Key Opportunities Prioritized 2.5. Industry Analysis - Porter's 2.6. Nanotechnology Healthcare market PESTEL Analysis, 2013 Chapter 3. Nanotechnology Healthcare Application Outlook 3.1. Drug Delivery System 3.1.1. Global revenue by region, 2016 - 2024 (USD Million) 3.2. Molecular Diagnostics 3.2.1. Global revenue by region, 2016 - 2024 (USD Million) 3.3. Clinical Oncology 3.3.1. Global revenue by region, 2016 - 2024 (USD Million) 3.4. Clinical Neurology 3.4.1. Global revenue by region, 2016 - 2024 (USD Million) 3.5. Clinical Cardiology 3.5.1. Global revenue by region, 2016 - 2024 (USD Million) 3.6. Anti-Inflammatory and Anti-Infective applications 3.6.1. Global revenue by region, 2016 - 2024 (USD Million) Chapter 4. Nanotechnology Healthcare Regional Outlook 4.1. North America 4.1.1. Market revenue by application, 2016 - 2024 (USD Million) 4.2. Europe 4.2.1. Market revenue by application, 2016 - 2024 (USD Million) 4.3. Asia Pacific 4.3.1. Market revenue by application, 2016 - 2024 (USD Million)

Follow Us:


Your Catalyst To a Lucrative Business 4.4. RoW 4.4.1. Market revenue by application, 2016 - 2024 (USD Million) Chapter 5 Competitive Landscape 5.1 Abbott Laboratories. 5.1.1 Company Overview 5.1.2 Financial Performance 5.1.3 Product Benchmarking 5.1.4 Strategic Initiatives 5.2 CombiMatrix Corporation 5.2.1 Company Overview 5.2.2 Financial Performance 5.2.3 Product Benchmarking 5.2.4 Strategic Initiatives 5.3 Celgene Corporation 5.3.1 Company Overview 5.3.2 Financial Performance 5.3.3 Product Benchmarking 5.3.4 Strategic Initiatives 5.4 Mallinckrodt plc. 5.4.1 Company Overview 5.4.2 Financial Performance 5.4.3 Product Benchmarking 5.4.4 Strategic Initiatives 5.5 GE Healthcare 5.5.1 Company Overview 5.5.2 Financial Performance 5.5.3 Product Benchmarking 5.5.4 Strategic Initiatives 5.6 Johnson & Johnson 5.6.1 Company Overview 5.6.2 Financial Performance 5.6.3 Product Benchmarking 5.6.4 Strategic Initiatives 5.7 Merck & Company Inc. 5.7.1 Company Overview 5.7.2 Financial Performance

Follow Us:


Your Catalyst To a Lucrative Business 5.7.3 Product Benchmarking 5.7.4 Strategic Initiatives 5.8 Nanosphere Inc. 5.8.1 Company Overview 5.8.2 Financial Performance 5.8.3 Product Benchmarking 5.8.4 Strategic Initiatives 5.9 Pfizer Inc. 5.9.1 Company Overview 5.9.2 Financial Performance 5.9.3 Product Benchmarking 5.9.4 Strategic Initiatives 5.10 Sigma-Tau Pharmaseuticals Inc. 5.10.1 Company Overview 5.10.2 Financial Performance 5.10.3 Product Benchmarking 5.10.4 Strategic Initiatives 5.11 Teva Pharmaseuticals Industries Ltd. 5.11.1 Company Overview 5.11.2 Financial Performance 5.11.3 Product Benchmarking 5.11.4 Strategic Initiatives 5.12 UCB SA 5.12.1 Company Overview 5.12.2 Financial Performance 5.12.3 Product Benchmarking 5.12.4 Strategic Initiatives Chapter 6. Methodology and Scope 6.1. Research Methodology 6.2. Research Scope & Assumption 6.3. List of Data Sources

Follow Us:


Your Catalyst To a Lucrative Business About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit Our Blog - https://hexaresearchinc.wordpress.com/

Follow Us:


Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.